Potent and selective p38α
= 6 nM). Exhibits 14-fold greater inhibition of p38α
compared to p38β
; also displays 300-fold selectivity for p38α
compared to a panel of 91 kinases. Exhibits anti-inflammatory properties.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Profiling of dihydroorotate dehydrogenase, p38 and JAK inhibitors in the rat adjuvant-induced arthritis model: a translational study.
Balagué et al.
Novel triazolopyridylbenzamides as potent and selective p38α inhibitors.
Aiguadé et al.